Clearmind Medicine (CMND) Research & Development (2022 - 2026)
Clearmind Medicine (CMND) reported Research & Development of $588,958 for fiscal Q3 2026 (quarter ended Jul 31, 2026), down 18.5% from $723,048 a year earlier and down 8.9% from the prior quarter.
Clearmind Medicine (CMND) Research & Development (2022 - 2026) Analysis & Trends
Over the twelve months ended Jul 31, 2026, Clearmind Medicine's Research & Development came in at $2.3 million, up 8.2% year-over-year; for FY2025 (ended Oct 31, 2025), it came in at $2.06 million, up 48.7% from FY2024.
- Research & Development has a four-year compound annual growth rate of 44.4% (FY2021 to FY2025).
- By fiscal year, Research & Development came in at $1.38 million in FY2024 (-10.5%), $1.54 million in FY2023 (-49.9%), $3.08 million in FY2022 (+550.5%) and $473,652 in FY2021.
- Five-year quarterly Research & Development spans a low of $12,746 in fiscal Q1 2024 and a high of $1.28 million in fiscal Q4 2022.
- Year over year, Research & Development gained in five of the last seven quarters, with growth averaging 32.6%.
- The high point for year-over-year Research & Development in five years was fiscal Q3 2025 (growth of 109.0%); the low point was fiscal Q1 2024 (a decline of 97.8%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $646,707 (Q2 2026), $640,494 (Q1 2026) and $420,182 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Clearmind Medicine | 10,040.11 | 10,040.11 | - | 588,958.00 |
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2026 | 588,958.00 |
| Apr 30, 2026 | 646,707.00 |
| Jan 31, 2026 | 640,494.00 |
| Oct 31, 2025 | 420,182.00 |
| Jul 31, 2025 | 723,048.00 |
| Apr 30, 2025 | 451,857.00 |
| Jan 31, 2025 | 461,438.00 |
| Oct 31, 2024 | 486,491.00 |
| Jul 31, 2024 | 345,883.00 |
| Apr 30, 2024 | 322,956.00 |
| Jan 31, 2024 | 12,746.00 |
| Oct 31, 2023 | 375,073.00 |
| Jul 31, 2023 | 263,954.00 |
| Apr 30, 2023 | 234,701.33 |
| Jan 31, 2023 | 587,630.00 |
| Oct 31, 2022 | 1.28 Mn |
| Jul 31, 2022 | 325,321.00 |
| Jan 31, 2022 | 335,201.61 |
Clearmind Medicine Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=CMND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "CMND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=CMND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();